A Frontline Solution from Neonates to Adults High velocity therapy is backed by a large and growing body of research across patient populations. Randomized controlled trials have shown high velocity therapy to be non-inferior to NiPPV in preventing intubation for spontaneously breathing patients, from premature babies in the NICU to COPD patients experiencing moderate to … Continue reading Homepage